Same Indication

Ipilimumab vs Lisinopril

Ipilimumab vs Lisinopril: Overview

This comparison examines the pharmacological differences between Ipilimumab and Lisinopril.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Lisinopril — 12 hours.

Chemical Properties

Molecular Formula: Lisinopril — C21H31N3O5.

Molecular Weight: Lisinopril — 405.4900 g/mol.

Type: Ipilimumab — Antibody; Lisinopril — Small molecule.